University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 19 of 23
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
NCT01269710
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
NCT00961233
Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
NCT00959894
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
NCT01031706
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease
NCT00998244
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
NCT01000766
Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?
NCT01526213
Shoulder Injury Prevention Program in Swimmers
NCT00998777
Pre-Exposure Prophylaxis in YMSM
NCT01033942
FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
NCT01028820
Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse
NCT01029197
Motivational Enhancement System for Adherence
NCT01009749
The Use of a Language Toolkit for Toddlers
NCT00926510
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
NCT00616200
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
NCT00855088
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
NCT00932282
Nutrition for Chronic Daily Headache
NCT01157208
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414
Study of Parenting Intervention to Prevent Child Obesity
NCT00998348
Burn Healing and Analgesia With Propranolol
NCT00934947
Dexmedetomidine Sedation With Third Molar Surgery
NCT01017237
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
NCT00932828
Colon Cancer Prevention Study
NCT00924690
A Pilot Study of Early Postpartum Intrauterine Contraception
NCT00997932
Physiological Effects of Yogurt With Bb12 in Subjects With GI Symptoms Strointestinal Symptoms
NCT01004484
Linkage to Care - Part II
NCT00891644
A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers
NCT00924768
Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung
NCT00902707
Salivary Inflammatory Biomarkers: Predictors & Comparative Effects of Sonicare/Elite-Flexcare in Stages of Perio Disease
NCT02187185
Oral Immunotherapy (OIT) for Peanut Allergy
NCT00815035
Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)
NCT00858130
Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
NCT00878137
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
NCT00873782
Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
NCT01111721
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00855413
Treatment De-Intensification and Residual HIV-1 in Youth
NCT00867854
Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects
NCT00840723
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
NCT01072916
Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans
NCT01634776
A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals
NCT00839124
The Weight-Wise Weight Loss Translation Study
NCT01141348
ID and Testing Via Friendship Networks
NCT00841360
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903
A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
NCT00834899
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
NCT00836368
Empowerment Intervention for Young Women - Phase I
NCT00891358
Haufen Diagnostic Biomarkers of BK Renal Disease
NCT01094691
Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
NCT00934362
Single Dose Truvada in HIV-negative Men and Women
NCT01326221
Media Effects Study on Health-Related Content
NCT00775008
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.